Open Access

Potassium binding in heart failure management: Enabling guideline-recommended RAASi therapy

Event: ESC Congress 2021 - The Digital Experience
Topic: Chronic Heart Failure
Session type: Satellite Symposium
sponsored by PACE-CME
Date: 30 August 2021
Time: 13:00 - 13:45

Session

This content is currently on OPEN ACCESS

Sign in to view the resources

4 presentations in this session

Heart Failure in Clinical Practice: Why monitor hyperkalemia?

Speaker: Professor S. Anker (Berlin, DE)
Thumbnail

RAASi as fundamental pillar in heart failure: The challenges to optimize management.

Speaker: Professor A. Coats (Coventry, GB)
Thumbnail

The clinical dilemma of RAASi & hyperkalemia: When and how to introduce potassium binding?

Speaker: Professor J. Butler (Jackson, US)
Thumbnail

Live discussion: The new ESC Heart Failure guidelines & potassium binding: What will change?

Thumbnail

3 speakers from this session

Professor Stefan Anker

Charite Campus Virchow Clinic, Berlin (Germany)
106 presentations
2 followers

Professor Andrew Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)
88 presentations
4 followers

Professor Javed Butler

University of Mississippi, Jackson (United States of America)
65 presentations
3 followers

Related content

ESC Premium Access

SGLT-2 inhibition: Winning battles in heart failure

3 December 2021

ESC Premium Access

Evolving role of SGLT2i in HFrEF management

3 December 2021

ESC Premium Access

Update on endocarditis in 2021

3 December 2021

This platform is supported by

logo Novo Nordisk